Literature DB >> 12846771

Infective endocarditis in dialysis patients: new challenges and old.

Timothy Doulton1, Nikhant Sabharwal, Hugh S Cairns, Silke Schelenz, Susannah Eykyn, Patrick O'Donnell, John Chambers, Conell Austen, David J A Goldsmith.   

Abstract

BACKGROUND: Since the 1960s chronic hemodialysis (HD) has been recognized as a risk factor for the development of infective endocarditis (IE). Historically, it has been particularly associated with vascular access via dual lumen catheters. We wished to examine the risk factors for, and consequences of, IE in the modern dialysis era.
METHODS: Cases of IE (using the Duke criteria) at St. Thomas' Hospital (1980 to 1995), Guy's (1995 to 2002), and King's College Hospitals (1996 to 2002) were reviewed.
RESULTS: Twenty-eight patients were identified as having developed IE (30 episodes of IE). Twenty-seven patients were on long-term HD and one patient was on peritoneal dialysis (PD). Mean age was 54.1 years, and mean duration of HD prior to IE was 46.3 months. Eight patients were diabetic. Primary HD hemoaccess was an arteriovenous fistula (AVF) in 41.3%, a dual-lumen tunneled catheter (DLTC) in 37.9%, a polytetrafluoroethylene (PTFE) graft in 10.3%, and a dual- lumen non-tunneled catheter (DLNTC) in 4%. The presumed source of sepsis was directly related to hemoaccess in 25 HD patients: DLTC in 48%; AVF in 32%; PTFE in 12%; and DLNTC in 4%. Staphylococcus aureus[including methicillin resistant Staphylococcus aureus (MRSA)] was present in 63.3%. The mitral valve was affected in 41.4% of patients, aortic valve in 37.9% of patients, and both valves were affected in 17.2% of patients. Of note, 51.7% of patients had an abnormal valve before the episode of IE. In 15 cases surgery was undertaken. Fourteen patients survived to discharge, and 12 survived for 30 days. In 15 cases antibiotic treatment alone was employed; in this case, eight patients died and seven survived to discharge.
CONCLUSION: This is the largest reported confirmed IE series in dialysis patients. Infective endocarditis in HD patients remains a challenging problem-although hemoaccess via dual-lumen catheters remains a significant risk, many cases developed in patients with AVFs and this group suffered the greatest mortality. An abnormal valve (frequently calcified) was another risk factor; because valve calcification is now common after 5 years on dialysis, more effort in preventing this avoidable form of ectopic calcification may reduce the risk of developing IE.

Entities:  

Mesh:

Year:  2003        PMID: 12846771     DOI: 10.1046/j.1523-1755.2003.00136.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  21 in total

1.  Characteristics and analysis of risk factors for mortality in infective endocarditis.

Authors:  Hakan Leblebicioglu; Hava Yilmaz; Yesim Tasova; Emine Alp; Rabin Saba; Rahmet Caylan; Mehmet Bakir; Ayhan Akbulut; Bilgin Arda; Saban Esen
Journal:  Eur J Epidemiol       Date:  2006       Impact factor: 8.082

2.  Infective endocarditis giving rise to peritonitis in a patient on peritoneal dialysis.

Authors:  M J Tsai; W C Yang; T W Chen; C C Lin
Journal:  Perit Dial Int       Date:  2013 Jul-Aug       Impact factor: 1.756

3.  A revealing murmur.

Authors:  Patrícia Rodrigues; Sofia Cabral; Mário Santos; Maria João Sousa; Bruno Brochado; Paulo Palma; Severo Torres
Journal:  J Echocardiogr       Date:  2015-06-23

4.  A case of histopathologically confirmed infective endocarditis with no vegetations observed during preoperative diagnosis.

Authors:  Takaya Sasaki; Shiko Gen; Kazuhiro Takahashi; Kanako Nobe; Naofumi Ikeda
Journal:  CEN Case Rep       Date:  2015-12-09

5.  Infective Endocarditis and Chronic Kidney Disease: How to Deal with Complications.

Authors:  Yusra Habib Khan; Azmi Sarriff; Amer Hayat Khan; Adnan Azreen Syazril; Tauqeer Hussain Mallhi
Journal:  Malays J Med Sci       Date:  2015 Jul-Aug

6.  Current features of infective endocarditis in persons on hemodialysis: a prevalence study with case control design from the prospective multicenter SEI cohort.

Authors:  Emanuele Durante-Mangoni; Pia Clara Pafundi; Veronica Ravasio; Francesco Barbaro; Matteo Bassetti; Pierangelo Chinello; Marco Falcone; Maria Bruna Pasticci; Pier Giorgio Scotton; Roberto Stellini; Marie-Françoise Tripodi; Riccardo Utili; Marco Rizzi
Journal:  Infection       Date:  2016-01-19       Impact factor: 3.553

7.  How best to deal with endocarditis.

Authors:  Andrew Mark Morris
Journal:  Curr Infect Dis Rep       Date:  2006-01       Impact factor: 3.725

8.  Infective endocarditis in hemodialysis patients: clinical features, echocardiographic data and outcome: a 10-year descriptive analysis.

Authors:  Sofiene Rekik; Imen Trabelsi; Mourad Hentati; Adnene Hammami; Mounir Ben Jemaa; Jamil Hachicha; Samir Kammoun
Journal:  Clin Exp Nephrol       Date:  2009-04-21       Impact factor: 2.801

9.  Risk of Infective Endocarditis in Patients with End Stage Renal Disease.

Authors:  Mavish S Chaudry; Nicholas Carlson; Gunnar H Gislason; Anne-Lise Kamper; Marianne Rix; Vance G Fowler; Christian Torp-Pedersen; Niels E Bruun
Journal:  Clin J Am Soc Nephrol       Date:  2017-10-03       Impact factor: 8.237

Review 10.  Infective endocarditis caused by Salmonella enteritidis in a dialysis patient: a case report and literature review.

Authors:  Yusuke Tsugawa; Miyuki Futatsuyama; Keiichi Furukawa; Fumika Taki; Yuji Nishizaki; Keiichi Tamagaki; Yuki Kaneshiro; Yasuhiro Komatsu
Journal:  BMC Infect Dis       Date:  2009-09-29       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.